ENTITY
Ascentage Pharma Group Corp

Ascentage Pharma Group Corp (6855 HK)

32
Analysis
Health CareChina
Ascentage Pharma Group International operates as a clinical-stage biotechnology company. The Company develops novel therapies for cancers, hepatitis B virus, age-related diseases, and more. Ascentage Pharma Group International conducts businesses in China, the United States, and other countries.
more
Refresh
Publication Icon
No publications yet
There aren’t any broker reports right now
Back to "All"
x